Teza Capital Management LLC Vericel Corp Transaction History

Teza Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$32.52 - $52.33 $101,397 - $163,164	-3,118 Reduced 39.41%	4,793 $249,000
Q4 2023 Feb 14, 2024	SELL	$30.85 - $37.09 $185,994 - $223,615	-6,029 Reduced 43.25%	7,911 $281,000
Q3 2023 Feb 22, 2024	SELL	$31.69 - $39.25 $18,538 - $22,961	-585 Reduced 7.2%	7,535 $252,000
Q3 2023 Nov 14, 2023	SELL	$31.69 - $39.25 $6,274 - $7,771	-198 Reduced 1.4%	13,940 $467,000
Q2 2023 Feb 22, 2024	BUY	$29.0 - $38.37 $6,061 - $8,019	209 Added 2.64%	8,120 $305,000
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $180,264 - $238,507	6,216 Added 78.47%	14,138 $531,000
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $188,939 - $248,275	7,922 New	7,922 $232,000

284

49.2M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.75B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.